Tauopathies

Tauopathies are a class of neurodegenerative diseases characterized by the abnormal aggregation of tau protein in the brain. In Alzheimer's disease, tau proteins become hyperphosphorylated and form neurofibrillary tangles, disrupting neuronal function. This accumulation leads to cell death and is a hallmark of dementia. Unlike other dementias that might involve amyloid plaques, tauopathies primarily focus on the tau protein abnormalities. Understanding tau pathology is crucial for developing targeted therapies aimed at stabilizing tau or preventing its aggregation. Research into tauopathies not only aids in comprehending Alzheimer’s disease but also provides insights into other tau-related disorders, offering broader implications for neurodegenerative disease treatment.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Whatsapp